Mechanisms of developmental regulation in globin loci

Current Opinion in Hematology

Volumn 5, Issue 2, 1998, Pages 139-144

  Fraser, Peter ^a   Gribnau, Joost ^a   Trimborn, Tolleiv ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLOBIN; BETA GLOBIN; TRANS ACTING FACTOR;

CHROMATIN; DEVELOPMENTAL GENETICS; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE SWITCHING; GLOBIN GENE; PRIORITY JOURNAL; REVIEW;

EID: 0031946862     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-199803000-00009     Document Type: Review

References (49)

1. Hardison R, Chao KM, Schwartz S, Stojanovic N, Ganetsky M, Miller W: Globin gene server: a prototype e-mail database server featuring extensive multiple alignments and data compilation. Genomics 1994, 21:344-353.
2. Kiousiss D, Vanin E, deLange T, Flavell RA, Grosveld F: β-globin gene inactivation by DNA translocation. Nature 1983, 306:662-666.
3. Forrester WC, Epner E, Driscoll MC, Enver T, Brice M, Papayannopoulou T, Groudine M: A deletion of the human β-globin locus activation region causes a major alteration in chromatin structure and replication across the entire β-globin locus. Genes Dev 1990, 4:1637-1649.
4. Bernet A, Sabatier S, Picketts DJ, Ouazana R, Morle F, Higgs DR, Godet J: Targeted inactivation of the major positive regulatory element (HS-40) of the human α-globin gene locus. Blood 1995, 86:1202-1211.
5. Grosveld F, Blom van Assendelft G, Greaves DR, Kollias G: Position-independent, high level expression of the human β-globin gene in transgenic mice. Cell 1987, 51:975-985.
6. Sharpe JA, Chan-Thomas PS, Lida J, Ayyub H, Wood WG, Higgs DR: Analysis of the human α-globin upstream regulatory element (HS-40) in transgenic mice. EMBO J 1992, 11:4564-4570.
7. Sharpe JA, Wells DJ, Whitelaw E, Vyas P, Higgs DR, Wood WG: Analysis of the human α-globln gene cluster in transgenic mice. Proc Natl Acad Sci U S A 1993, 90:11262-11266.
8. Enver T, Raich N, Ebens AJ, Papayannopoulou T, Constantini F, Stamatoyannopoulous G: Developmental regulation of human fetal-to-adult globin gene switching in transgenic mice. Nature 1990, 344:309-313.
9. Hanscombe O, Whyatt D, Fraser P, Yannoutsos N, Greaves D, Dillon N, Grosveld F: Importance of globin gene order for correct developmental expression. Genes Dev 1991, 5:1387-1394.
10. Peterson KR, Stamatoyannopoulous G: Role of gene order in developmental control of human gamma- and beta-globin gene expression. Mol Cell Biol 1993, 13:4836-4843.
11. Raich N, Enver T, Nakamoto B, Josephson B, Papayannopoulou T, Stamatoyannopoulous G: Autonomous developmental control of human embryonic globin gene switching in transgenic mice. Science 1990, 250:1147-1149.
12. Dillon N, Grosveld F: The human γ-globin genes silenced independently of other genes in the β-globin locus. Nature 1991, 350:252-254.
13. Li Q, Stamatoyannopoulous J: Position independence and proper developmental control of γ-globin gene expression require both a 5′ locus control region and a downstream sequence element. Mol Cell Biol 1994, 14:6087-6096.
14. Stamatoyannopoulos JA, Clegg CH, Li Q: Sheltering of gamma-globin expression from position effects requires both an upstream locus control region and a regulatory element 3′ to the A gamma-globin gene. Mol Cell Biol 1997, 17:240-247.
15. Dillon N, Strouboulis J, Grosveld F: The regulation of human β-globin gene expression: polarity of transcriptional competition in the human β-globin locus. In Molecular Biology of Hemoglobin Switching, Proceedings of the Ninth Conference on Hemoglobin Switching held at Orcas Island, Washington. Edited by Stamatoannopoulos G. 1995, pp 23-28. Andover: Intercept Limited; 1995:23-28.
16. Dillon N, Trimborn T, Strouboulis J, Fraser P, Grosveld F: The effect of distance on long range chromatin interactions. Mol Cell 1998, in press. Expression analysis in full locus transgenics in which a marked beta gene was placed at different positions in the locus. Primary transcript in situ hybridization data show that the LCR proximal β-gene has a distinct advantage over the distal β-gene in cis and results in the proximal gene being transcribed much more frequently than the distal gene. The mRNA expression levels of the different genes are directly proportional to the percentages of active genes in the population, showing again that a gene is either fully on or off.
17. Wijgerde M, Grosveld F, Fraser P: Transcription complex stability and chromatin dynamics. Nature 1995, 377,209-213.
18. Martin DIK, Fienng S, Groudine M: Regulation of β-globin gene expression: straightening out the locus. Curr Opin Genet Dev 1996, 6:488-495.
19. Kong S, Bohl D, Li C, Tuan D: Transcription of the HS2 enhancer toward a cis-linked gene is independent of the orientation, position and distance of the enhancer relative to the gene. Mol Cell Biol 1997, 17:3955-3965.
20. Donze D, Townes TM, Bieker JJ: Role of erythroid Kruppel like factor in human γ- to β-globin gene switching. J Biol Chem 1995, 270:1955-1959.
21. Nuez B, Michalovich D, Bygrave A, Ploemacher R, Grosveld F: Defective haematopoiesis in fetal liver resulting from inactivation of the EKLF gene. Nature 1995, 375:316-318.
22. Perkins AC, Sharpe AH, Orkin SH: Lethal β-thalassemia in mice lacking the erythroid CACCC-transcrlption factor EKLF. Nature 1995, 375:318-322.
23. -/- mice shows that DNAse I hypersensitivity of HS3 and the β promoter are reduced and increased at the γ promoter, consistent with the increase in active γ genes in the population. These data are discussed in terms of the looping model and suggest that EKLF is important for the LCR/β-gene interaction.
24. -/- background β-globin expression was absent, and γ-globin was increased approximately fivefold. Burst forming unit-erythroid colonies derived from these mice showed similar results and excluded anemic stress as the cause of increased γ-globin expression. These data are discussed within the context of EKLF,s key role in facilitating the probability of β globin over γ globin expression.
25. Foley KP, Engel JD: Individual stage selector element mutations lead to reciprocal changes in beta- vs. epsilon-globin gene transcription: genetic confirmation of promoter competition during globin gene switching. Genes Dev 1992, 6:730-744.
26. Shehee R, Oliver P, Smithies O: Lethal thalassemla after insertional diruption of the mouse major adult beta-globin gene. Proc Natl Acad Sci U S A 1993, 90:3177-3181.
27. Skow LC, Burkhart BA, Johnson FM, Popp RA, Popp DM, Golberg SZ, Anderson WF, Barnett LB, Lewis SE: A mouse model for β-thalassemia. Cell 1983, 34:1043-1052.
28. Curcio MJ, Kantoff P, Schafer MP, Anderson WF, Safer B: J Biol Chem 1986, 261:16126-16132.
29. A-globin gene in transgenic mice. Nature 1990, 348:749-752.
30. Smetanina NS, Leonova JY, Levy N, Huisman THJ: The α/β- and α2/α1-globin mRNA ratios in different forms of α-thalassemia. Biochem Biophys Acta 1996, 1315:188-192.
31. Leder A, Daugherty C, Whitney B, Leder P: Mouse zeta- and alpha-globin genes: embryonic survival, alpha-thalassemia, and genetic background effects. Blood 1997, 90:1275-1282. Knockout of the mouse ζ and α genes by insertion of selectable marker genes. Interestingly, marker gene insertion into the ζ gene leads to reductions in the level of α gene expression in the fetal and adult periods, suggesting that the marker gene may be competing for activation with the α genes.
32. Pham CT, MacIvor DM, Hug BA, Heusel JW, Ley TJ: Long range disruption of gene expression by a selectable marker cassette. Proc Natl Acad Sci U S A 1996, 93:13090-13095.
33. Fraser P, Pruzina S, Antoniou M, Grosveld F: Each hypersensitive site of the human β globin locus control region confers a different developmental pattern of expression to the globin genes. Genes Dev 1993, 7:106-113.
34. Starck J, Sarkar R, Romana M, Bhargava A, Scarpa AL, Tanaka M, Chamberlain JW, Weissman SM, Forget B: Developmental regulation of human γ- and β-globin genes in the absence of the locus control region. Blood 1994, 84:1656-1665.
35. Arcasoy MO, Romana M, Fabry ME, Skarpidi E, Nagel RL, Forget BG: High levels of human γ-globin gene expression in adult mice carrying a transgene of deletion-type hereditary persistence of fetal hemoglobin. Moll Cell Biol 1997, 17:2076-2089.
36. Milot E, Strouboulis J, Trimborn T, Wijgerde M, de Boer E, Langeveld A, Tan-Un K, Vergeer W, Yannoutsos N, Grosveld F, Fraser P: Heterochromatin effects on the frequency and duration of LCR-mediated gene transcription. Cell 1996, 87:105-114. Thorough analysis of full-locus transgenic mice with small deletions of the individual HS of the LCR. The data show that deletion of a single HS results in mild to severe reductions in expression owing to position effects at the site of integration in the host genome. Two different position effect mechanisms were noted. Reduced expression in the case of position effect variegation is caused by stable silencing of the transgene in a clonal subpopulation of erythroid cells. Cell timing effect results in low-level transgene expression in all erythroid cells, but transcription of the transgene is switched on and off in response to cellular signals.
37. Bungert J, Dave U, Lim KC, Lieuw KH, Shavit JA, Liu Q, Engel JD: Synergistic regulation of human β-globin gene switching by locus control region elements HS3 and HS4. Genes Dev 1995, 9:3083-3096.
38. Peterson K, Clegg C, Navas P, Norton A, Kimbrough T, Stamatoyannopoulous G: Effect of deletion of 5′ HS3 or 5′ HS2 of the human β-globin LCR on the developmental regulation of globin gene expression in β globin locus YAC transgenic mice. Proc Natl Acad Sci U S A 1996, 93:6605-6609.
39. Hug BA, Wesselschmidt RL, Fiering S, Bender MA, Epner E, Groudine M, Ley TJ: Analysis of mice containing a targeted deletion of β-globin locus control region 5′ hypersensitive site 3. Moll Cell Biol 1996, 16:2906-2912.
40. Fiering S, Epner E, Robinson K, Zhuang Y, Telling A, Hu M, Martin DI, Enver T, Ley TJ, Groudine M: Targeted deletion of 5′ HS2 of the murine β-globin LCR reveals that it is not essential for proper regulation of the β-globin locus. Genes Dev 1995, 9:2203-2213.
41. Karpen GH: Position effect variegation and the new biology of heterochromatin. Curr Opin Genet Dev 1994, 4:281-291.
42. Huisman THJ, Schroeder WA, Efremov GD, Duma H, Mladenovskil B, Hyman CB, Rachmilewitz EA, Bouver N, Miller A, Brodie A, Shelton JR, Shelton JB, Apell G: The present status of the heterogeneity of fetal hemoglobin in β-thalassemia: an attempt to unify some observations in thalassemia and related conditions. Ann NY Acad Sci 1974, 232:107-124.
43. Bernards R, Flavell RA: Physical mapping of the globin gene deletion in hereditary persistence of foetal haemoglobin (HPFH). Nucleic Acids Res 1980, 8:1521-1534.
44. Collins FS, Weisman SM: The molecular genetics of human hemoglobin. Prog Nucleic Acid Res Mol Biol 1984, 31:315-461.
45. Papayannopoulou T, Brice M, Stamatoyannopoulous G: Analysis of human hemoglobin switching in MEL X human fetal erythroid cell hybrids. Cell 1986, 46:469-476.
46. Stanworth SJ, Roberts NA, Sharpe JA, Sloane-Stanley JA, Wood WG: Established epigenetic modifications determine the expression of developmentlly regulated globin genes in somatic cell hybrids. Mol Cell Biol 1995, 15:3969-3978.
47. Stanworth SJ, Roberts NA, Sharpe JA, Wood WG: Gene expression in somatic cell hybrids derived from embryonic mice transgenic for human globin genes. Br J Haematol 1996, 94:631-638.
48. Liu Q, Bungert J, Engel JD: Mutation of gene-proximal regulatory elements disrupts human epsilon-, gamma-, and beta-globin expression in yeast artificial chromosome transgenic mice. Proc Natl Acad Sci U S A 1997, 94:169-174. YAC transgenics with small deletions of either the ε silencer or the 3′ β enhancer show that expression of both ε and γ is disrupted in embryonic cells with silencer mutations and expression of both γ and β is disrupted in fetal cells with β-enhancer mutations. A number of possible mechanisms are discussed that could account for the observed effects, including the idea of separate chromatin domains.
49. Roberts NA, Sloane-Stanley JA, Sharpe JA, Stanworhth SJ, Wood WG: Globin gene switching in transgenic mice carrying HS2-globin gene constructs. Blood 1997, 89:713-723.